Tamoksifen (Serbian Wikipedia)
Analysis of information sources in references of the Wikipedia article "Tamoksifen" in Serbian language version.
refsWebsite
Global rank
Serbian rank
1st place
1st place
6th place
5th place
low place
low place
1,684th place
703rd place
archive.org
- VC, Jordan (1993). „Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer”. Br J Pharmacol. 110 (2): 507—17. PMC 2175926
. PMID 8242225.
cancer.gov
- National Cancer Institute (26. 04. 2006). „Study of Tamoxifen and Raloxifene (STAR) Trial”. U.S. National Institutes of Health. Архивирано из оригинала 04. 07. 2007. г. Приступљено 03. 07. 2007.
cancerhelp.org.uk
- „Breast cancer in men”. CancerHelp UK. Cancer Research UK. 28. 09. 2007. Архивирано из оригинала 01. 12. 2008. г. Приступљено 22. 03. 2009.
doi.org
- VC, Jordan (2006). „Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer”. Br J Pharmacol. 147 (Suppl 1): S269—76. PMC 1760730 . PMID 16402113. doi:10.1038/sj.bjp.0706399.
dslrf.org
- Susan Love (22. 04. 2006). „Study Finds New Use for Raloxifene: Reducing Breast Cancer in High-Risk Postmenopausal Women”. Архивирано из оригинала 02. 08. 2009. г. Приступљено 19. 03. 2009.
fda.gov
- Center for Drug Evaluation and Research (03. 08. 2005). „Tamoxifen Information: reducing the incidence of breast cancer in women at high risk”. U.S. Food and Drug Administration. Архивирано из оригинала 19. 06. 2007. г. Приступљено 03. 07. 2007.
nejm.org
content.nejm.org
- Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer Архивирано на сајту Wayback Machine (9. јануар 2010), The BIG 1-98 Collaborative Group, New England Journal of Medicine , 361:766 Aug. 20, 2009
nih.gov
ncbi.nlm.nih.gov
- VC, Jordan (2006). „Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer”. Br J Pharmacol. 147 (Suppl 1): S269—76. PMC 1760730 . PMID 16402113. doi:10.1038/sj.bjp.0706399.
- VC, Jordan (1993). „Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer”. Br J Pharmacol. 110 (2): 507—17. PMC 2175926 . PMID 8242225.
pitt.edu
nsabp.pitt.edu
- University of Pittsburgh. „STAR Study of Tamoxifen and Raloxifen”. Архивирано из оригинала 11. 06. 2007. г. Приступљено 03. 07. 2007.
web.archive.org
- Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer Архивирано на сајту Wayback Machine (9. јануар 2010), The BIG 1-98 Collaborative Group, New England Journal of Medicine , 361:766 Aug. 20, 2009
- „Breast cancer in men”. CancerHelp UK. Cancer Research UK. 28. 09. 2007. Архивирано из оригинала 01. 12. 2008. г. Приступљено 22. 03. 2009.
- Center for Drug Evaluation and Research (03. 08. 2005). „Tamoxifen Information: reducing the incidence of breast cancer in women at high risk”. U.S. Food and Drug Administration. Архивирано из оригинала 19. 06. 2007. г. Приступљено 03. 07. 2007.
- National Cancer Institute (26. 04. 2006). „Study of Tamoxifen and Raloxifene (STAR) Trial”. U.S. National Institutes of Health. Архивирано из оригинала 04. 07. 2007. г. Приступљено 03. 07. 2007.
- University of Pittsburgh. „STAR Study of Tamoxifen and Raloxifen”. Архивирано из оригинала 11. 06. 2007. г. Приступљено 03. 07. 2007.
- Susan Love (22. 04. 2006). „Study Finds New Use for Raloxifene: Reducing Breast Cancer in High-Risk Postmenopausal Women”. Архивирано из оригинала 02. 08. 2009. г. Приступљено 19. 03. 2009.